Figure 2. DRFS of RAD54B high and low groups.
A. Kaplan–Meier survival analyses of 108 stage I–III CRC patients in the training set revealed that the RAD54B high group had inferior DRFS compared with the low group (P = 0.0013). B. Kaplan–Meier survival analyses of 71 stage I–III CRC patients in the validation set revealed that the RAD54B high group had inferior DRFS compared with the low group (P = 0.024).